High-risk breast programs increase rates of early cancer detection, improving patient outcomes, lowering the cost of care and engaging patients in...
How NCCN Guidelines and the Tyrer-Cuzick Lifetime Model differ and why programs are missing patients.
The changing season is the perfect time for health systems to upgrade their screening programs to support cancer prevention and early detection...
CancerIQ data shows 2 in 5 patients who undergo comprehensive cancer risk assessment and genetic testing require a change in medical management.
Breast center providers including mammography techs, nurses, and clinicians, as well as the patients they serve deserve a tool that helps them follow...
What separates the genetics programs that succeed from those that don’t? Learn how your health system can address this gap by working with CancerIQ...
The changing season is the perfect time for health systems to upgrade their screening programs to support cancer prevention and early detection...
Genetic counselors are an invaluable resource for early cancer detection and precision cancer prevention. Today this limited workforce is focused on...
In a recent webinar hosted by the Association of Cancer Executives, CancerIQ’s Senior Vice President of Commercial Strategy, John Hansel, discussed...
Genomics has an established benefit in precision cancer care for patients and providers alike – but its positive financial impact on your health...